Consolidated Statements of Operations - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Grant and collaboration revenue | $ 385,501 | $ 1,823,658 |
| Operating expenses: | ||
| Research and development | 15,554,171 | 2,444,459 |
| General and administrative | 3,577,153 | 2,196,014 |
| Total operating expenses | 19,131,324 | 4,640,473 |
| Loss from operations | (18,745,823) | (2,816,815) |
| Other income (expense): | ||
| Interest income | 4,736 | 2,271 |
| Interest expense | (1,286) | (143,524) |
| Gain on debt extinguishment | 172,056 | |
| Total other income (expense) | 175,506 | (141,253) |
| Net loss | $ (18,570,317) | $ (2,958,068) |
| Basic and diluted: | ||
| Net loss per common share (in dollars per share) | $ (3.04) | $ (2.14) |
| Weighted average shares outstanding (in shares) | 6,099,933 | 1,383,829 |